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Abstract 
Background: Hematological reference values are important for the clinical decisions in laboratory diagnosis and 
monitoring of patients. The correct interpretation of laboratory results depends entirely on the reference intervals that 
have been established for the locality. But, in sub-Saharan African countries particularly in Ethiopia, locally derived ref-
erence intervals were not established and they are forced to use intervals established from western population. Thus 
this study aimed to establish locally derived hematological reference values that could be used in Northwest Ethiopia.
Methods: A cross sectional study was conducted from April to May 2014 with 120 male and 120 female apparently 
health adult blood donors at Gondar University Hospital. A structured pretested questionnaire was used for socio 
demographic and clinical data collection. About 4 ml of blood was collected with EDTA test tube and analyzed using 
Cell-Dyn 1800 to enumerate the hematological parameters. The data were collected and entered into SPSS version 
20 for analysis. Mann–Whitney U test was used to determine reference intervals and Harris and Boyd test was used to 
determine the reference intervals that need partition. The 95th percentile of measurements was taken as a reference 
interval.
Results: Median and 95th percentile of WBC for general population were lower than Caucasian population, Addis 
Ababa, Burkina Faso and Kenya of similar studies. The RBC, Hgb and PCV lower 95% limit values of both sex were lower 
than studies in Addis Ababa, Kenya, Burkina Faso and text book. While PCV upper limit values higher than the above 
countries. MCV values of the current study were higher than those countries while MCHC values were lower. Similarly, 
the absolute values of neutrophils in the current study were lower than Caucasian and Afro Caribbean but higher 
than African countries and Jamaica but lymphocyte count was higher.
Conclusions: The hematological reference intervals established in this study was different from those reported in 
other part of Ethiopia or African countries as well as Caucasian population. The RBC, PCV, Hgb and MCHC reference 
intervals were different in gender. Thus, using of locally determined reference range is advisable.
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Background
Hematological reference values are necessary in rou-
tine assessments for diagnosis of blood disorders, infec-
tious diseases, immune status, and diseases progression 
and also in assessment of response to antiretroviral 
treatment. Locally-derived age-specific hematologi-
cal reference ranges were also recommended for proper 
patient managements and interpretation of results [1].
In the use and interpretation of laboratory test results, it 
is important to understand the limitations of tests. These 
include the ability of the test to indicate the presence or 
absence of disease or whether the value in a report is nor-
mal or abnormal for a patient. These sounds the knowl-
edge of reference value for a particular laboratory test is 
very crucial in patient management. The laboratory staff 
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and those requesting tests should know the accepted ref-
erence ranges and clinical significance of the results of the 
quantitative tests performed in the laboratory. This will 
ensure that significantly abnormal results are detected, 
checked, reported, and acted on as soon as possible [2].
There is a difference in reference ranges related to age, 
sex, geographic origin, altitude, and ethnic background 
in addition to hemoglobin abnormalities (thalassemia, 
sickle cell disease and hemoglobin C) or pathologic con-
ditions (malaria, HIV and other viral infections) pre-
vented to have one common hematological values for all 
countries [2–7]. Thus, the use of normal hematological 
values derived from other African countries could result 
in incorrect patient management in routine clinical care.
The reference intervals for analysis of hematological 
parameters during routine clinical activities in Ethio-
pia or Africa are reference texts generated from Cauca-
sian adult populations living in developed countries [8]. 
Lower values for hemoglobin, red blood cells, hemato-
crit, mean corpuscular volumes, platelets and neutro-
phils and higher monocytes and eosinophils levels were 
reported in African population compared to similar pop-
ulation in Western counter parts [6, 9–12]. Also there are 
ample evidences that clinicians and medical researchers 
should use method-specific reference ranges in their lab-
oratories which account for gender differences and vari-
ances in the ethnic composition of the local society [13], 
but this is not done in developing countries.
An increasing number of clinical trials taking place in 
Africa are seeking to identify safe and effective prevention 
and treatment strategies to combat the heavy burden of 
infectious diseases in this region but there is only attempts 
to establish standard reference hematological intervals 
[14], there is lack of well-established reference intervals.
In the absence of locally derived reference intervals, 
clinicians and researchers have to use reference values 
of western population’s, thus it is important to establish 
local hematological reference intervals for appropriate 
diagnosis, treatment, and follow up of patients. The ref-
erence intervals that are currently used in Ethiopia are 
adopted from textbooks that refer mainly to Caucasian 
subjects. But one study in Ethiopia conducted in south-
east Addis Ababa showed lower WBC and platelet values 
of healthy HIV negative Ethiopians than the adopted ref-
erence values [15]. Thus, the main aim of this study was 
to establish locally derived hematological reference val-
ues that could be used in Northwest Ethiopia.
Methods
Study setting and population
A cross sectional study was conducted from April to June 
2014 at Gondar University Hospital blood banking center. 
The hospital is located in Gondar town which is 740  km 
from the capital of Ethiopia, Addis Ababa, in the Northwest 
of Ethiopia. The city has a latitude and longitude of 12°36′N 
and 37°28′E with an elevation of 2133 meters above sea 
level. Based on figures from the Central Statistical Agency 
of Ethiopia in 2007, Gondar has an estimated total popu-
lation of 231,977. Gondar University Hospital is the only 
referral hospital with more than 400 beds for North West 
Ethiopia serving a population of about 5 million. The con-
secutive nonparametric method was based solely on the 
ranks of the observations (in order of magnitude) and 
ignores their measured values. According to the National 
Committee for Clinical Laboratory Standards (NCCLS), 
International Federation of Clinical Chemistry (IFCC) and 
Clinical Laboratory Standards Institute (CLIS) Guideline 
recommendations, a minimum size of 120 observations 
from each category is needed [16]. Based on this guide line 
120 male and 120 female study participants who pass the 
exclusion/inclusion criteria were selected conveniently. 
The reference individuals were selected based on medical 
examinations, current health status, blood pressure, taking 
any medication, working with hazardous chemicals, alcohol 
intake, presence of inherited health disorder in the family, 
tuberculosis, lymphadenopathy, weight loss, regular exer-
cise, tobacco smoking, allergy manifestation, fever, malaria, 
HIV, hepatitis B virus surface antigen (HbsAg), hepatitis C 
virus antibodies (HcAbs), menstruation, pregnancy and use 
of contraceptives. After written informed consents were 
taken from study subjects, 4  ml of venous blood samples 
were collected immediately following the donation in tube 
containing EDTA and 4 ml bloods with plan tube for sero-
logical analysis was taken and proceed.
Laboratory investigation
About 4  ml of venous blood was collected by an expe-
rienced laboratory technologist from each subject for 
hematological parameters analysis. Hematological 
parameters; total white cell count (WBC), differential 
white cell count (neutrophils, lymphocytes, eosinophils, 
monocytes and basophiles), platelet count, red blood 
cell count (RBC), hemoglobin (Hgb), hematocrit (%), 
mean cell volume (MCV), mean cell hemoglobin (MCH), 
mean cell hemoglobin concentration (MCHC), and red 
cell distribution width (RDW) were determined using 
the automated blood analyzer Cell-Dyne 1800 (Abbott 
Laboratories Diagnostics Division, USA).The other 4  ml 
of blood after clotting the serum was separated and 
serological tests (HIV, HbsAg, and HcAbs) was assayed. 
Erythrocyte sedimentation rate (ESR) was done by using 
westerngreen method for 1 h.
Statistical analysis
Data was cleaned, edited, checked for completeness and 
entered into Epi-Info version 3.3.5 and then transferred to 
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SPSS version 20 for statistical analysis. The mean, median 
and standard deviation of hematological reference inter-
vals were determined using descriptive statistics. Mann–
Whitney U test was used to determine reference intervals 
and also Harris and Boyd test was used to determine the 
reference intervals that need partition (Table 2). The 95th 
percentile was taken as a reference interval.
Results
Socio demographic characteristics
A total of 120 male and 120 female adult healthy subjects 
from Gondar University Hospital Blood Bank Centre 
were included in this study. The mean age of the study 
subjects was 24.50 ± 6.65 years with age range from 18 
to 50  years and about 69.6% were within age range of 
18–25 years. From the study subjects 78.3% were living in 
Gondar town, 26.7% were married, 58.3% were students 
and 89.2% were orthodox in religion (Table 1).
Hematological reference interval
In order to determine hematological parameters that 
need combined or partition reference interval based on 
sex, Harris and Boyd test was used. Basing this test par-
titioned reference interval was determined for RBC, 
PCV, Hgb, MCH and MCHC (Table 2). Median and 95th 
percentile of WBC, absolute neutrophils, absolute lym-
phocytes, absolute mixed cell, platelet, MCV, RDW and 
ESR were 5.1 (3.2–8.8 × 109/l), 2.7 (1.6–5.1 × 109/l), 1.9 
(1–3.5 × 109/l), 0.5 (0.2–1 × 109/l), 264 (128–432 × 109/l), 
92 (85–100 fl); 14 (12–17%) and 5 (0–15 mm/h) respec-
tively for the general population (Table 3).
Box and Whisker plots indicate the effect of sex on 
hematological parameters of the study participants 
(Fig. 1). The median and 95th percentile reference inter-
vals for RBC, Hgb, PCV, MCH and MCHC were 5.01 
(3.53–6.93 × 1012/l), 46.9 (36.2–58.6%), 14.2 (11.5–18 g/
dl) and 31.3 (29.5–34.4  g/dl) respectively for males and 
4.8 (3.45–6.25 ×  1012/l), 45.2 (32.1–56.6%), 12.9 (11–16 
g/dl) and 30.8 (28.5–34.4  g/dl) respectively for females 
(Table 3).
Discussion
This study showed a significant gender differences for the 
RBC parameters (RBC, Hgb, PCV, MCH and MCHC). 
The finding agrees with the well-established fact that 
males have higher values than female. While there was 
no significant differences between genders with regard to 
WBC parameters, platelet counts, ESR, MCV and RDW. 
This was also in agreement with previously carried out 
studies in Addis Ababa and other African countries [1, 
6, 15, 17–19] (Tables  4, 5 and 6). The significant differ-
ence between male and female may be due to biologi-
cal and physiological factors such as the influence of the 
Table 1 The socio demographic characteristics of  adult 
of Gondar participated in the study
Variables Socio demographic 
characteristics
Frequency Percentage (%)
Sex Male 120 50
Female 120 50
Age group (years) 18–25 167 69.6
26–35 51 21.2
>35 22 9.2
Address Gondar 188 78.9
Around gondar 52 21.1
Marital status Married 64 26.7
Single 174 72.5
Divorced 2 0.8
Religion Orthodox 214 89.2
Muslim 22 9.2
Protestant 1 0.4
Others 3 1.2
Occupation Civil servant 21 8.8
Private 36 15.0
House wife 6 2.5
Farmer 37 15.4
Students 120 58.3
Table 2 Result of  Harris and  Boyd test, which was per-
formed to see the need for partitioning of Reference inter-
val based on sex
Z† = critical value, Z* = calculated value, Separate RI are needed only when Z† is 
greater than Z*, P value is derived from Mann–Whitney U test
Italic values indicate hematological parameters which need partition between 
male and female (Z† > Z*)
Parameters P value Harris and Boyd
Z* Z† Decision
WBC (×109/l) 0.3779 3 0.4 No separate RI
Neutrophil (%) 0.7239 3 0.6 No separate RI
Neutrophils absolute (×109/l) 0.6331 3 0.01 No separate RI
Lymphocyte (%) 0.6750 3 0.5 No separate RI
Lymphocytes absolute (×109/l) 0.1705 3 0.9 No separate RI
Mixed (%) 0.5375 3 0.5 No separate RI
Mixed absolute (×109/l) 0.2784 3 0.5 No separate RI
Platelet (×109/l) 0.0223 3 2.3 No separate RI
RBC (×1012/l) 0.0016 3 3.4 Separate RI
Hgb (g/dl) <0.0001 3 5.6 Separate RI
PCV (%) 0.0033 3 3.4 Separate RI
MCH (pg) 0.0016 3 3.1 Separate RI
MCHC (g/dl) <0.0001 3 5.0 Separate RI
MCV (fl) 0.2929 3 0.3 No separate RI
RDW 0.9577 3 0.6 No separate RI
ESR (mm/h) 0.3283 3 0.9 No separate RI
Page 4 of 9Yalew et al. BMC Res Notes  (2016) 9:483 
hormone androgen on erythropoiesis and also due to 
menstrual blood loss in females
The 95th percentile reference interval of the cur-
rent study lower limit of RBC in both sexes, were lower 
than studies conducted in Addis Ababa Ethiopia, Kenya, 
Burkina Faso and text books while the upper limit was 
higher than the above mentioned studies (Tables 4, 5 and 
6). Comparison of hematological results with this study 
indicated that similarity could not be found based on 
geographical proximity, this may be due to difference in 
altitude, method and instrument used for analysis [6, 8, 
15, 18].
The lower limit of hemoglobin reference interval in 
this study was lower than a study conducted in Addis 
Ababa and text books while higher than studies con-
ducted in Kenya and Burkina Faso for both genders. On 
the other hand the upper limit of Hgb was higher than 
Addis Ababa, text books, Kenya, and Burkina Faso. This 
difference may be due to altitude and ethnic variations. 
Thus, it may not be possible, even, to have one stand-
ard reference between two localities in the same county 
as experienced in Kenya. Similarly the lower limit refer-
ence intervals of PCV in both sexes was lower than study 
conducted in Addis Ababa, text books and higher than 
studies conducted in Kenya and Burkina Faso. While the 
upper limit was higher than studies carried out in Addis 
Ababa, Kenya, Burkina Faso and text books [6, 8, 15, 18]. 
Likewise of RBC and Hgb the difference in the reference 
interval values might arise from differences in altitude 
and ethnical variations.
The current study reference interval values of MCV 
are generally higher than values indicated in different 
African countries. The lower limit values of MCH in 
both sexes in this study was higher than a study con-
ducted in Burkina Faso, but the upper limit was compa-
rable, but the established values of MCHC in both sexes 
was generally lower than values indicated in different 
African countries [6, 18]. The WBCs reference intervals 
established for the general population in the current 
study was lower than the values described for Caucasian 
population in different text books, Addis Ababa, Burkina 
Faso and Kenya. However, median and 95 percentile 
Table 3 Median, IQR, range and  95th percentile of  reference interval, P values of  hematological parameters for  adult 
in Gondar, northwestern Ethiopia
Parameters N Median (IQR) Range (min–max) RI (95th percentile) Lower limit 90% CI Upper limit 90% CI
WBC (×109/l) 240 5.1 (4.2–6.3) 2.7–9.5 3.2–8.8 3.2 (2.9–3.5) 8.8 (8.3–9.1)
Neutrophil (%) 240 53 (48–58) 30–77 36–69 36 (33.8–39.1) 69 (66.9–76.5)
Neutrophils absolute (×109/l) 240 2.7 (2.1–3.5) 1.3–7.3 1.6–5.1 1.6 (1.3–1.7) 5.1 (4.6–6.2)
Lymphocyte (%) 240 38 (33–42) 17–56 22–55 22 (18.2–24.9) 55 (52.4–55.9)
Lymphocytes absolute (×109/l) 240 1.9 (1.5–2.3) 0.70–5.0 1–3.5 1 (0.8–1.1) 3.5 (3.2–4.2)
Mixed (%) 240 9 (8–11) 4–18 6–13 6 (5.4–6.4) 13 (13.0–18.0)
Mixed absolute (×109/l) 240 0.50 (0.4–0.6) 0.2–1.2 0.2–1 0.2 (0.2–0.3) 1.0 (0.9–1.2)
MCV (fl) 240 92 (90–94) 78–105 85–100 85 (80.3–85.1) 100 (99–102)
Platelet (×109/l) 240 264 (210–312) 110–531 128–432 128 (115–140) 432 (403–496)
ESR (mm/h) 240 5.0 (0–5) 0–20 0–15 0 (0–0) 15 (15–20)
RDW 240 14 (13–14) 12–18 12–17 12 (12–12.7) 17 (15.5–18.3)
RBC (×1012/l)
 Male 120 5.01 (4.56–5.59) 3.12–6.95 3.53–6.93 3.53 (3.12–3.9) 6.93 (6.45–6.95)
 Female 120 4.8 (4.2–5.25) 3.0–6.50 3.45–6.25 3.45 (3.0–3.57) 6.25 (6.08–6.5)
Hgb (g/dl)
 Male 120 14.2 (13.1–15.5) 11.0–19.1 11.5–18.0 11.5 (11–11.9) 18.0 (17.9–19.1)
 Female 120 12.9 (12.0–14.3) 10.9–16.9 11.0–16.7 11.0 (10.9–11.3) 16.7 (16.2–16.9)
PCV (%)
 Male 120 46.9 (43.2–50.0) 34.5–60.2 36.2–58.6 36.2 (34.5–37.6) 58.6 (57.0–60.2)
 Female 120 45.2 (40.4–48) 30.8–59.0 32.1–56.6 32.1 (30.8–36) 56.6 (52.1–59)
MCH (pg)
 Male 120 29.0 (28–30) 26–34.0 26.6–33.3 26.6 (25.7–27.1) 33.3 (32–34)
 Female 120 28.6 (27.7–29.2) 25.6–33.1 25.8–32.8 25.8 (25.6–26.4) 32.8 (31–33.1)
MCHC (g/dl)
 Male 120 31.3 (30.6–32.4) 28.0–36.5 29.5–34.4 29.5 (28–30) 34.4 (33.6–36.5)
 Female 120 30.8 (30.0–31.2) 28.0–34.7 28.5–34.4 28.5 (28–29) 34.4 (32.5–34.7)
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ranges of neutrophils and lymphocytes of this study 
compared with similar study conducted on Caucasian, 
African, Afro-Caribbean and Jamaican population, neu-
trophils were lower than Caucasian and Afro-Caribbean, 
but higher than African and Jamaica. Lymphocyte count 
in the current study was higher than Caucasian and 
African black population [6, 8, 15, 18]. The difference 
between the current result and other findings might be 
due to geographical differences, environment, diet, and 
ethnic background [16].
The median and 95th percentile range values of ESR 
was at normal range with no difference for male and 
female as all the recruited subjects were healthy, not 
exposed to inflammatory conditions associated with sys-
temic inflammatory diseases [20].
Conclusions
Haematological reference intervals established from 
adult healthy population of Northwest Ethiopia 
(Gondar and surrounding areas) were different from 
Caucasian and African counties. The haematologi-
cal intervals were also different from previous results 
obtained in other part of Ethiopia. Intervals for red 
blood cell count, hematocrit values, hemoglobin 
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concentration, MCH and MCHC were different for 
male and female but there was no difference in WBC 
parameters, PLT, MCV, RDW and ESR.Further studies 
on haematological intervals for all age groups are rec-
ommended for locally derived standard haematological 
intervals (Additional file 1).
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Table 6 Comparisons of median and 95% reference range with Eastern and Southern Africa (18), Tanzania (19), Togo (20) 
and Uganda (21) of African countries
Abs absolute
Parameters Gondar Togo Tanzania Uganda Eastern and southern Africa
Median (95% range) Median (95% range) Median (95% range) Median (95% range) Median (95% range)
WBC (×109/l) 5.1 (3.2–8.8) 4.1 (1.9–10.1) 4.6 (3.0–7.9) 4.9 (2.8–8.2) 3.1–9.1
Neutrophils (Abs) 2.7 (1.6–5.1) 1.6 (0.5–5.4) 2.2 (1.1–4.7) NA 1.0–5.3
Neutrophils (%) 53 (36–69) NA 48.1 (32.0–69.1) 38.9 (22.2–59.3) 25–66
Lymphocyte (Abs) 1.9 (1–3.5) 2.1 (1.1–4.3) 1.8 (1.1–3.0) NA 1.2–3.7
Lymphocyte (%) 38 (22–55) NA 40.5 (20.8–56.7) 44.4 (26.7–61.2) 23–59
Mixed (Abs) 0.5 (0.2–1) NA 0.5 (0.3–1.1) NA NA
Mixed (%) 9 (6–13) NA 10.3 (5.6–19.8) NA NA
Platelet (×109/l) 264 (128–432) 239 (120–443) 244 (150–398) 218.5 (109–384) 126–438
MCV (fl) 92 (85–100) 84.5 (80–99) 89.4 (77.6–98.1) 85 (71–97) 68–98
RBC (×1012/l)
 Male 4.8 (3.45–6.25) 5.0 5.0 (3.3–6.4) 5.21 (4.41–6.27) 5.0 (3.8–6.1) 4.0–6.4
 Female 1 (3.53–6.93) 4.5 (3.1–6.0) 4.69 (3.84–5.59) 4.4 (3.3–5.3) 3.8–5.6
Hgb (g/dl)
 Male 12.9 (11–16.7) 15.8 (10.0–18.4) 15.4 (13.7–17.7) 14.5 (11.6–17.1) 12.2–17.7
 Female 14.2 (11.5–18) 13.0 (10.3–17.1) 13.5 (11.1–15.7) 12.8 (9.8–16.2) 9.5–15.8
PCV (%)
 Male 45.2 (32.1–56.6) 42.8 (28.0–54.0) 46.6 (40.2–53.7) 42.6 (33.8–49.5) 35.0–50.8
 Female 46.9 (36.2–58.6) 38.1 (28.0–47.0) 41.5 (36.2–46.8) 37.8 (28.3–46.8) 29.4–45.4
MCH (pg)
 Male 28.6 (25.8–32.8) 29.7 (26–36) 30.0 (23.1–33.2) 29.2 (23.0–33.8) NA
 Female 29 (26.6–33.3) 29.3 (25–37) 29.3 (24.2–33.1) 29.5 (24.8–32.7) NA
MCHC (%)
 Male 30.8 (28.5–34.4) 35.1 (29–39) 33.3 (30.6–35.1) 34.2 (32.4–35.3) NA
 Female 31.3 (29.5–34.4) 35.1 (30–41) 32.7 (30.4–34.8) 34.2 (33.0–35.5) NA
RDW (%)
 Male 14 (12–17) NA NA 12.8 (10.9–16.8) NA
 Female 14 (12–17) NA NA 12.7 (11.0–17.3) NA
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